⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Table S7 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures

Stephen H. Chang Ryan J. Ice Michelle Chen Maxim Sidorov Rinette W.L. Woo Aida Rodriguez-Brotons Damon Jian Han Kyul Kim Angela Kim David E. Stone Ari Nazarian Alyssia Oh Gregory J. Tranah Mehdi Nosrati David de Semir Altaf A. Dar Pierre‐Yves Desprez Mohammed Kashani–Sabet Liliana Soroceanu Sean D. McAllister

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Supplementary Table 7 gene_importance_t0.1_limit4_ew

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chang et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522bbd https://doi.org/10.1158/1535-7163.27036364.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S7 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
2Table S2 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
3Table S2 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
4Table S1 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
5Table S3 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024

More related papers

Table S3 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
Table S8 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
Table S8 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024